# Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease

> **NCT00244582** · — · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 1 (—)

## Conditions studied

- Type 2 Gaucher Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00244582
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10-22
- **Primary completion:** —
- **Final completion:** 2006-11-03
- **Target enrollment:** 1 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244582, "Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00244582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*